The inhibition of the NF-κB pathway has been considered to efficiently provide neuroprotection via suppressed M1-like MM activation (Popiolek-Barczyk et al., 2015; Ślusarczyk et al., 2018). This evidence concerns the gene NFKB1 and Miyoshi myopathy.